Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

NCT06182358 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Demodex Blepharitis

Interventions

DRUG: Lotilaner ophthalmic solution, 0.25%
DRUG: Vehicle control

Sponsor

Tarsus Pharmaceuticals, Inc.